Unilife has entered of a seven-year commercial supply contract with an undisclosed pharmaceutical company for its Unifill prefilled syringe. The deal is for the planned launch of a generic equivalent of an approved auto-immune therapy that is currently available in a standard prefilled syringe format for use across several indications. The release of the generic drug utilizing the Unifill syringe will mark the first time an auto-immune therapy is supplied in a prefilled syringe with safety featu...